Apolipoprotein B and angiotensin-converting enzyme polymorphisms and aerobic interval training: randomized controlled trial in coronary artery disease patients

N Y Tamburus, R Verlengia, V C Kunz, M C César, E Silva, N Y Tamburus, R Verlengia, V C Kunz, M C César, E Silva

Abstract

Physical training has been strongly recommended as a non-pharmacological treatment for coronary artery disease (CAD). Genetic polymorphisms have been studied to understand the biological variability in response to exercise among individuals. This study aimed to verify the possible influence of apolipoprotein B (ApoB: rs1042031 and rs693) and angiotensin-converting enzyme (ACE-ID: rs1799752) genotypes on the lipid profile and functional aerobic capacity, respectively, after an aerobic interval training (AIT) program in patients with CAD and/or cardiovascular risk factors. Sixty-six men were randomized and assigned to trained group (n=32) or control group (n=34). Cardiopulmonary exercise test was performed to determine the ventilatory anaerobic threshold (VAT) from cardiorespiratory variables. The AIT program, at an intensity equivalent to %VAT (70-110%), was conducted three times a week for 16 weeks. ApoB gene polymorphisms (-12669C>T (rs1042031) and -7673G>A (rs693)) were identified by real-time polymerase chain reaction (PCR). I/D polymorphism in the ACE gene (rs1799752) was identified through PCR and fragment size analysis. After 16 weeks, low-density lipoprotein (LDL) levels increased in the trained and control groups with the GA+AA genotype (-7673G>A) of the ApoB gene. Trained groups with ACE-II and ACE-ID genotypes presented an increase in oxygen consumption (VO2VAT) and power output after the AIT program. The presence of the ACE I-allele was associated with increased aerobic functional capacity after the AIT program. Increased LDL levels were observed over time in patients with the -7673G>A polymorphism of the ApoB gene. Trial Registration Information: ClinicalTrials.gov: NCT02313831.

Figures

Figure 1.. Flow chart showing the participation…
Figure 1.. Flow chart showing the participation of patients in the study.
Figure 2.. Change in oxygen uptake (VO…
Figure 2.. Change in oxygen uptake (VO2) (A) and power output (B) at the ventilatory anaerobic threshold according to angiotensin-converting enzyme I/D (rs1799752) genotypes. I/D: insertion/deletion.

References

    1. Scheuner MT. Genetic evaluation for coronary artery disease. Genet Med. 2003;5:269–285. doi: 10.1097/01.GIM.0000079364.98247.26.
    1. Vanhees L, Rauch B, Piepoli M, van Buuren F, Takken T, Börjesson M, et al. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III) Eur J Prev Cardiol. 2012;19:1333–1356. doi: 10.1177/2047487312437063.
    1. Cornish AK, Broadbent S, Cheema BS. Interval training for patients with coronary artery disease: a systematic review. Eur J Appl Physiol. 2011;111:579–589. doi: 10.1007/s00421-010-1682-5.
    1. Pattyn N, Coeckelberghs E, Buys R, Cornelissen VA, Vanhees L. Aerobic interval training vs. moderate continuous training in coronary artery disease patients: a systematic review and meta-analysis. Sports Med. 2014;44:687–700. doi: 10.1007/s40279-014-0158-x.
    1. Conraads VM, Pattyn N, De Maeyer C, Beckers PJ, Coeckelberghs E, Cornelissen VA, et al. Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: The SAINTEX-CAD study. Int J Cardiol. 2015;179:203–210. doi: 10.1016/j.ijcard.2014.10.155.
    1. Tamburus NY, Kunz VC, Salviati MR, Castello Simões V, Catai AM, DA Silva E. Interval training based on ventilatory anaerobic threshold improves aerobic functional capacity and metabolic profile: a randomized controlled trial in coronary artery disease patients. Eur J Phys Rehabil Med. 2016;52:1–11.
    1. Holme I, Høstmark AT, Anderssen SA. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study. J Intern Med. 2007;262:235–243. doi: 10.1111/j.1365-2796.2007.01806.x.
    1. Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J Endocrinol Metab. 2013;17:969–976. doi: 10.4103/2230-8210.122600.
    1. Machado MO, Hirata MH, Bertolami MC, Hirata RD. ApoB gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal. 2001;15:19–24.
    1. Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G. ApoB gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis. 2003;167:355–366. doi: 10.1016/S0021-9150(02)00425-2.
    1. Defoor J, Vanhees L, Martens K, Matthijs G, Van Vlerken A, Zielinska D, et al. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart. 2006;92:527–528. doi: 10.1136/hrt.2004.054312.
    1. Cam S, Colakoglu M, Colakoglu S, Sekuri C, Berdeli A. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J Sports Med Phys Fitnes. 2007;47:234–238.
    1. Cerit M, Colakoglu M, Erdogan M, Berdeli A, Cam FS. Relationship between ACE genotype and short duration aerobic performance development. Eur J Appl Physiol. 2006;98:461–465. doi: 10.1007/s00421-006-0286-6.
    1. Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van Someren K, Montgomery HE. The ACE gene and human performance: 12 years on. Sports Med. 2011;41:433–448. doi: 10.2165/11588720-000000000-00000.
    1. Vaughan D, Huber-Abel FA, Graber F, Hoppeler H, Flück M. The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise. Eur J Appl Physiol. 2013;113:1719–1729. doi: 10.1007/s00421-012-2583-6.
    1. Danser AH, Batenburg WW, van den Meiracker AH, Danilov SM. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacol Ther. 2007;113:607–618. doi: 10.1016/j.pharmthera.2006.12.001.
    1. Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, Dollery C, et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet. 1999;353:541–545. doi: 10.1016/S0140-6736(98)07131-1.
    1. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000;85:575–579. doi: 10.1111/j.1469-445X.2000.02057.x.
    1. Wasserman K, Hansen JE, Sue D, Whipp BJ, Casaburi R. Principles of exercise testing and interpretation. 4th ed. Williams and Wilkins; Philadelphia: 1999.
    1. Zamunér AR, Catai AM, Martins LE, Sakabe DI, Da Silva E. Identification and agreement of first turn point by mathematical analysis applied to heart rate, carbon dioxide output and electromyography. Braz J Phys Ther. 2013;17:614–622. doi: 10.1590/S1413-35552012005000129.
    1. Higa MN, Silva E, Neves VF, Catai AM, Gallo L, Silva de Sá MF. Comparison of anaerobic threshold determined by visual and mathematical methods in healthy women. Braz J Med Biol Res. 2007;40:501–508. doi: 10.1590/S0100-879X2007000400008.
    1. Verlengia R, Rebelo AC, Crisp AH, Kunz VC, Dos Santos Carneiro Cordeiro MA, Hirata MH, et al. Lack of Association Between ACE Indel Polymorphism and Cardiorespiratory Fitness in Physically Active and Sedentary Young Women. Asian J Sports Med. 2014;5:e22768. doi: 10.5812/asjsm.22768.
    1. Sirol FN, Sakabe DI, Catai AM, Milan LA, Martins LEB, Silva E. Comparasion of power output and heart rate levels in anaerobic threshold determinations by two indirect methods. Braz J Phys Ther. 2005;9:7.
    1. Pithon KR, Martins LEB, Gallo L, Jr, Catai AM, Silva E. Comparison of cardiorespiratory responses between constant and incremental load exercises below, above and at the ventilatory anaerobic threshold. Braz J Phys Ther. 2006;10:6. doi: 10.1590/S1413-35552006000200005.
    1. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online. 2005;1:47–50. doi: 10.1177/117693430500100003.
    1. Benn M. Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis. 2009;206:17–30. doi: 10.1016/j.atherosclerosis.2009.01.004.
    1. Boekholdt SM, Peters RJ, Fountoulaki K, Kastelein JJ, Sijbrands EJ. Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis. Hum Genet. 2003;113:417–425. doi: 10.1007/s00439-003-0988-3.
    1. Borén J, Ekström U, Agren B, Nilsson-Ehle P, Innerarity TL. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem. 2001;276:9214–9218. doi: 10.1074/jbc.M008890200.
    1. Knott TJ, Pease RJ, Powell LM, Wallis SC, Rall SC, Jr, Innerarity TL, et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 1986;323:734–738. doi: 10.1038/323734a0.
    1. Yang CY, Chen SH, Ganturco SH, Bradley WA, Sparrow JT, Tanimura M, et al. Sequence, structure, receptor binding domains, and internal repeat of human apolipoprotein B-100. Nature. 1986;323:738–742. doi: 10.1038/323738a0.
    1. Iwanaga Y, Nishi I, Ono K, Takagi S, Tsutsumi Y, Ozaki M, et al. Angiotensin-converting enzyme genotype is not associated with exercise capacity or the training effect of cardiac rehabilitation in patients after acute myocardial infarction. Circ J. 2005;69:5. doi: 10.1253/circj.69.1315.
    1. Woods DR, World M, Rayson MP, Williams AG, Jubb M, Jamshidi Y, et al. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol. 2002;86:240–244. doi: 10.1007/s00421-001-0545-5.
    1. Zhang B, Sakai T, Miura S, Kiyonaga A, Tanaka H, Shindo M, et al. Association of angiotensin-converting-enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension. Clin Genet. 2002;62:328–333. doi: 10.1034/j.1399-0004.2002.620414.x.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel